(Q61979644)

English

Bortezomib and High-dose Melphalan at Myeloma Relapse

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

Phase II Study of Bortezomib Dexamethasone and High-dose Melphalan in Patients With Relapse After High-dose Melphalan With Autologous Stem Cell Support (English)
0 references
0 references
0 references
0 references
July 2007
0 references
June 2009
0 references
50
0 references
0 references
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit